Target intelligence / Profile preview

Werner helicase-interacting protein 1 (WRNIP1)

Target
WRNIP1
Molecular classification
Enzyme (AAA+ ATPase), DNA replication/repair protein, modulator of polymerase delta-mediated DNA synthesis
01

Overview

Werner helicase-interacting protein 1 (WRNIP1) is a highly conserved AAA+ ATPase that plays an essential role in maintaining genome integrity, primarily through its involvement in DNA replication and repair. WRNIP1 interacts with the WRN DNA helicase (mutated in Werner syndrome), DNA polymerase delta, RAD51, RAD18, and other replication/repair proteins, and contains an N-terminal ubiquitin-binding zinc finger domain, a central ATPase domain, and C-terminal leucine zipper motifs[2][4]. WRNIP1 functions in stabilization and restart of stalled replication forks, promotes translesion DNA synthesis upon DNA damage, and counteracts transcription-replication conflicts by resolving R-loops—non-canonical nucleic acid structures that disrupt genome stability if not properly managed[1][3][4]. Depletion of WRNIP1 leads to increased genomic instability, accumulation of G-quadruplex DNA structures, impaired DNA replication, and elevated DNA damage—defects that echo those found in aging and cancer. Though WRNIP1 is not directly targeted by approved drugs, it represents a promising therapeutic target candidate in diseases of genomic instability[1][2][4].

Other names
WRNIP1ATPase WRNIP1WHIPFLJ22526bA420G6.2FAP93CFAP93Werner helicase-interacting protein 1putative helicase RUVBL
02

Mechanism of action

Not applicable—no drugs currently target WRNIP1 directly.

03

Biological functions

DNA replication fork protectionTranslesion DNA synthesis (TLS)Genome maintenanceRegulation of R-loop dynamicsDNA damage responseModulation of DNA polymerase delta-mediated synthesisInnate immune defense (RIG-I pathway)
04

Disease associations

Cancer (related to genomic instability)Premature aging disorders (e.g., Werner syndrome)Bloom syndromeOther genome instability-related conditions
05

Safety considerations

No established therapeutic interventionspotential concerns if modulated, include increased genomic instabilityimpaired DNA replicationpossible predisposition to cancer and aging disorders

Beyond the preview

Go deeper on Werner helicase-interacting protein 1 (WRNIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Werner helicase-interacting protein 1 (WRNIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call